A 5-Pathway Signature Predicts Prognosis Based on Immune-Derived lncRNAs in Patients with Breast Cancer.
Bo LiuNian ZhuHuixia HuoJunqi LongXinchan JiJinmeng LiXujie ZhuangHuina WangLujia LiYuhaoran ChenWei YangShuangtao ZhaoPublished in: Journal of oncology (2022)
This 5-pathway signature correlated with immune-derived lncRNAs was able to precisely predict the prognosis for patients with BRCA and provided a rich source characterizing immune-related lncRNAs and further informed strategies to target BRCA vulnerabilities.